Search

Search Constraints

You searched for: Author/Creator Song, Kevin W.

Search Results

1. Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia. (12th August 2022)

2. Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma. (29th September 2021)

3. Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab. (9th May 2018)

4. Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma. Issue 2 (1st February 2017)

5. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Issue 1 (1st January 2020)

6. Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort. (14th February 2022)

7. Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients. (4th February 2020)

8. Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials. Issue 12 (1st December 2016)

9. Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure. (6th October 2019)

10. Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS). Issue 12 (1st December 2016)